AquaBounty Technologies (NASDAQ:AQB) Releases Quarterly Earnings Results

AquaBounty Technologies (NASDAQ:AQB) posted its earnings results on Thursday. The company reported ($0.20) earnings per share for the quarter, Zacks reports.

AquaBounty Technologies Price Performance

Shares of AQB traded down $0.01 during trading hours on Thursday, hitting $0.95. The company’s stock had a trading volume of 55,474 shares, compared to its average volume of 41,033. The company has a market cap of $4.89 million, a price-to-earnings ratio of -1.14 and a beta of 1.36. The business has a 50 day simple moving average of $0.94 and a two-hundred day simple moving average of $0.98. AquaBounty Technologies has a 52-week low of $0.61 and a 52-week high of $2.95.

Hedge Funds Weigh In On AquaBounty Technologies

A hedge fund recently raised its stake in AquaBounty Technologies stock. Renaissance Technologies LLC raised its holdings in AquaBounty Technologies, Inc. (NASDAQ:AQB) by 311.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 121,585 shares of the company’s stock after purchasing an additional 92,065 shares during the period. Renaissance Technologies LLC owned 3.14% of AquaBounty Technologies worth $113,000 at the end of the most recent reporting period. Institutional investors own 8.92% of the company’s stock.

About AquaBounty Technologies

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.